Search Results - "Haass, Christian"

Refine Results
  1. 1

    If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? by Haass, Christian, Selkoe, Dennis

    Published in PLoS biology (21-07-2022)
    “…Strong genetic evidence supports an imbalance between production and clearance of amyloid β-protein (Aβ) in people with Alzheimer disease (AD). Microglia that…”
    Get full text
    Journal Article
  2. 2

    Initiation and propagation of neurodegeneration by Haass, Christian

    Published in Nature medicine (01-11-2010)
    “…Although substantial progress has been made in understanding the molecular and pathological bases of neurodegeneration, there have been few successes in the…”
    Get full text
    Journal Article
  3. 3

    Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease by Lewcock, Joseph W., Schlepckow, Kai, Di Paolo, Gilbert, Tahirovic, Sabina, Monroe, Kathryn M., Haass, Christian

    Published in Neuron (Cambridge, Mass.) (09-12-2020)
    “…Alzheimer’s disease (AD) is currently untreatable, and therapeutic strategies aimed to slow cognitive decline have not yet been successful. Many of these…”
    Get full text
    Journal Article
  4. 4

    Stress granules in neurodegeneration – lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma by Bentmann, Eva, Haass, Christian, Dormann, Dorothee

    Published in The FEBS journal (01-09-2013)
    “…Stress granules (SGs) are cytoplasmic foci that rapidly form when cells are exposed to stress. They transiently store mRNAs encoding house‐keeping proteins and…”
    Get full text
    Journal Article
  5. 5

    Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences by Exner, Nicole, Lutz, Anne Kathrin, Haass, Christian, Winklhofer, Konstanze F

    Published in The EMBO journal (18-07-2012)
    “…Neurons are critically dependent on mitochondrial integrity based on specific morphological, biochemical, and physiological features. They are characterized by…”
    Get full text
    Journal Article
  6. 6

    Microglia states and nomenclature: A field at its crossroads by Paolicelli, Rosa C., Sierra, Amanda, Stevens, Beth, Tremblay, Marie-Eve, Aguzzi, Adriano, Ajami, Bahareh, Amit, Ido, Audinat, Etienne, Bechmann, Ingo, Bennett, Mariko, Bennett, Frederick, Bessis, Alain, Biber, Knut, Bilbo, Staci, Blurton-Jones, Mathew, Boddeke, Erik, Brites, Dora, Brône, Bert, Brown, Guy C., Butovsky, Oleg, Carson, Monica J., Castellano, Bernardo, Colonna, Marco, Cowley, Sally A., Cunningham, Colm, Davalos, Dimitrios, De Jager, Philip L., de Strooper, Bart, Denes, Adam, Eggen, Bart J.L., Eyo, Ukpong, Galea, Elena, Garel, Sonia, Ginhoux, Florent, Glass, Christopher K., Gokce, Ozgun, Gomez-Nicola, Diego, González, Berta, Gordon, Siamon, Graeber, Manuel B., Greenhalgh, Andrew D., Gressens, Pierre, Greter, Melanie, Gutmann, David H., Haass, Christian, Heneka, Michael T., Heppner, Frank L., Hong, Soyon, Hume, David A., Jung, Steffen, Kettenmann, Helmut, Kipnis, Jonathan, Koyama, Ryuta, Lemke, Greg, Lynch, Marina, Majewska, Ania, Malcangio, Marzia, Malm, Tarja, Mancuso, Renzo, Masuda, Takahiro, Matteoli, Michela, McColl, Barry W., Miron, Veronique E., Molofsky, Anna Victoria, Monje, Michelle, Mracsko, Eva, Nadjar, Agnes, Neher, Jonas J., Neniskyte, Urte, Neumann, Harald, Noda, Mami, Peng, Bo, Peri, Francesca, Perry, V. Hugh, Popovich, Phillip G., Pridans, Clare, Priller, Josef, Prinz, Marco, Ragozzino, Davide, Ransohoff, Richard M., Salter, Michael W., Schaefer, Anne, Schafer, Dorothy P., Schwartz, Michal, Simons, Mikael, Smith, Cody J., Streit, Wolfgang J., Tay, Tuan Leng, Tsai, Li-Huei, Verkhratsky, Alexei, von Bernhardi, Rommy, Wake, Hiroaki, Wittamer, Valérie, Wolf, Susanne A., Wu, Long-Jun, Wyss-Coray, Tony

    Published in Neuron (Cambridge, Mass.) (02-11-2022)
    “…Microglial research has advanced considerably in recent decades yet has been constrained by a rolling series of dichotomies such as “resting versus activated”…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Regulated intramembrane proteolysis – lessons from amyloid precursor protein processing by Lichtenthaler, Stefan F., Haass, Christian, Steiner, Harald

    Published in Journal of neurochemistry (01-06-2011)
    “…J. Neurochem. (2011) 117, 779–796. Regulated intramembrane proteolysis (RIP) controls the communication between cells and the extracellular environment. RIP is…”
    Get full text
    Journal Article
  9. 9

    Young microglia restore amyloid plaque clearance of aged microglia by Daria, Anna, Colombo, Alessio, Llovera, Gemma, Hampel, Heike, Willem, Michael, Liesz, Arthur, Haass, Christian, Tahirovic, Sabina

    Published in The EMBO journal (01-03-2017)
    “…Alzheimer′s disease (AD) is characterized by deposition of amyloid plaques, neurofibrillary tangles, and neuroinflammation. In order to study microglial…”
    Get full text
    Journal Article
  10. 10
  11. 11

    An Alzheimer‐associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function by Schlepckow, Kai, Kleinberger, Gernot, Fukumori, Akio, Feederle, Regina, Lichtenthaler, Stefan F, Steiner, Harald, Haass, Christian

    Published in EMBO molecular medicine (01-10-2017)
    “…Sequence variations occurring in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2) support an essential function of microglia and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases by Winklhofer, Konstanze F, Tatzelt, Jörg, Haass, Christian

    Published in The EMBO journal (23-01-2008)
    “…The etiologies of neurodegenerative diseases may be diverse; however, a common pathological denominator is the formation of aberrant protein conformers and the…”
    Get full text
    Journal Article
  14. 14

    Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects by Vassar, Robert, Kuhn, Peer‐Hendrik, Haass, Christian, Kennedy, Matthew E., Rajendran, Lawrence, Wong, Philip C., Lichtenthaler, Stefan F.

    Published in Journal of neurochemistry (01-07-2014)
    “…The β‐site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein…”
    Get full text
    Journal Article
  15. 15

    Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury by Suárez-Calvet, Marc, Araque Caballero, Miguel Ángel, Kleinberger, Gernot, Bateman, Randall J, Fagan, Anne M, Morris, John C, Levin, Johannes, Danek, Adrian, Ewers, Michael, Haass, Christian

    Published in Science translational medicine (14-12-2016)
    “…Emerging evidence supports a role for innate immunity and microglia in Alzheimer's disease (AD) pathophysiology. However, no marker related to microglia has…”
    Get more information
    Journal Article
  16. 16

    ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import by Dormann, Dorothee, Rodde, Ramona, Edbauer, Dieter, Bentmann, Eva, Fischer, Ingeborg, Hruscha, Alexander, Than, Manuel E, Mackenzie, Ian R A, Capell, Anja, Schmid, Bettina, Neumann, Manuela, Haass, Christian

    Published in The EMBO journal (18-08-2010)
    “…Mutations in fused in sarcoma ( FUS ) are a cause of familial amyotrophic lateral sclerosis (fALS). Patients carrying point mutations in the C‐terminus of FUS…”
    Get full text
    Journal Article
  17. 17

    TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance by Xiang, Xianyuan, Werner, Georg, Bohrmann, Bernd, Liesz, Arthur, Mazaheri, Fargol, Capell, Anja, Feederle, Regina, Knuesel, Irene, Kleinberger, Gernot, Haass, Christian

    Published in EMBO molecular medicine (01-09-2016)
    “…Immunotherapeutic approaches are currently the most advanced treatments for Alzheimer's disease (AD). Antibodies against amyloid β‐peptide (Aβ) bind to amyloid…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations by Mackenzie, Ian R., Arzberger, Thomas, Kremmer, Elisabeth, Troost, Dirk, Lorenzl, Stefan, Mori, Kohji, Weng, Shih-Ming, Haass, Christian, Kretzschmar, Hans A., Edbauer, Dieter, Neumann, Manuela

    Published in Acta neuropathologica (01-12-2013)
    “…Hexanucleotide repeat expansion in C9ORF72 is the most common genetic cause of frontotemporal dementia and motor neuron disease. Recently, unconventional…”
    Get full text
    Journal Article
  20. 20